Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
- - - - - - - 0
0,6%0,68%16.94x1.97x3.69x9.97x10.92x 66,56 Md
0,55%0,57%28.53x4.29x5.87x17.23x21.78x 57,64 Md
-.--%-.--%34.88x7x11.82x22.38x26.3x 42,24 Md
3,49%3,58%-43.93x2.4x3.11x9.2x10.74x 39,09 Md
-.--%-.--%34.9x1.72x3.71x11.39x13.26x 31,91 Md
-.--%-.--%-9.24x5.42x13.4x-8.22x-7.78x 31,65 Md
-.--%-.--%16.96x3.4x3.25x9.83x9.74x 23,35 Md
-.--%0,05%53.7x5.43x5.97x40.99x38.22x 18,92 Md
-.--%-.--%26.89x3.78x5.5x14.75x20.45x 17,17 Md
-.--%-.--%-35.48x-6.16x16.45x-50.02x-51.98x 15,12 Md
-.--%-.--%-123.95x12940.15x12.65x-112.04x-123.11x 12,57 Md
0,15%0,15%64.31x26.22x39.1x55.3x57.03x 12,22 Md
-.--%-.--%16.75x - 3.57x13.08x15.68x 11,4 Md
-.--%-.--%48.65x - - - - 11,06 Md
2,8%3,24%11.98x1.04x1.81x7.3x9.78x 6,27 Md
1,56%1,73%14.43x1.33x2.56x6.62x8.02x 5,78 Md
-.--%-.--%-106.91x - - - - 5,24 Md
Moyenne 0,54% 0,59% 2,91x 928,43x 8,83x 3,18x 3,94x 22,68 Md
Moyenne pondérée par Capi. 0,58% 0,61% 10,39x 431,46x 7,61x 7,83x 9,29x
Biopharmacies